Mallinckrodt Plans $1.6B Opioid Trust In $5.3B Del. Ch. 11
Bankrupt global pharmaceutical company Mallinckrodt PLC reported spending a "staggering" $1 million per week on opioid suit defenses Monday, in an opening declaration for a $5.3 billion Delaware bankruptcy that calls...To view the full article, register now.
Already a subscriber? Click here to view full article